66 related articles for article (PubMed ID: 3263310)
1. [The effect of Campath-1 on T- and NK-cells].
Schofer O; Veit BC; Johnson FL
Immun Infekt; 1988 Aug; 16(4):143-7. PubMed ID: 3263310
[TBL] [Abstract][Full Text] [Related]
2. Quantity and nature of residual bone marrow T cells after treatment of the marrow with Campath-1.
Irlé C; Kaestli M; Aapro M; Chapuis B; Jeannet M
Exp Hematol; 1987 Feb; 15(2):163-70. PubMed ID: 3545877
[TBL] [Abstract][Full Text] [Related]
3. Purging in auto- and allografts: monoclonal antibodies which use human complement and other natural effector mechanisms.
Cobbold SP; Hale G; Clark MR; Waldmann H
Prog Clin Biol Res; 1990; 333():139-51; discussion 152-4. PubMed ID: 2308978
[TBL] [Abstract][Full Text] [Related]
4. T-cell depletion of Cercopithecus aethiops monkey bone marrow with Campath-1 monoclonal antibody and complement.
Phan DT; Barta E; Gidáli J; Fehér I; Harsányi V; Petrányi GG; Hollán SR
Haematologia (Budap); 1987; 20(3):155-63. PubMed ID: 3500899
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of megakaryocytopoiesis by Campath-1G-treated natural killer cells.
Nagler A; Condiotti R; Lubina A; Deutsch VR
Bone Marrow Transplant; 1997 Oct; 20(7):525-31. PubMed ID: 9337053
[TBL] [Abstract][Full Text] [Related]
6. Campath-1G impairs human natural killer (NK) cell-mediated cytotoxicity.
Condiotti R; Nagler A
Bone Marrow Transplant; 1996 Oct; 18(4):713-20. PubMed ID: 8899185
[TBL] [Abstract][Full Text] [Related]
7. Depletion of T cells from human bone marrow using monoclonal antibodies and rabbit complement. A quantitative and functional analysis.
Rohatiner A; Gelber R; Schlossman SF; Ritz J
Transplantation; 1986 Jul; 42(1):73-80. PubMed ID: 3487857
[TBL] [Abstract][Full Text] [Related]
8. Effect of cyclosporin A on lymphopoiesis. III. Augmentation of the generation of natural killer cells in bone marrow transplanted mice treated with cyclosporin A.
Kosugi A; Shearer GM
J Immunol; 1991 Mar; 146(5):1416-21. PubMed ID: 1993836
[TBL] [Abstract][Full Text] [Related]
9. Control of graft-versus-host disease and graft rejection by T cell depletion of donor and recipient with Campath-1 antibodies. Results of matched sibling transplants for malignant diseases.
Hale G; Waldmann H
Bone Marrow Transplant; 1994 May; 13(5):597-611. PubMed ID: 8054913
[TBL] [Abstract][Full Text] [Related]
10. Cercopithecus aethiops monkey as a reliable model for in vitro study of T cell depletion of bone marrow with Campath-1 plus complement.
Phan DT; Benczur M; Gidáli J; Fehér I; Harsányi V; Nemes L; Petrányi G; Hollán SR
Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(1):97-106. PubMed ID: 2472335
[TBL] [Abstract][Full Text] [Related]
11. G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation: comparison of T cell depletion strategies using different CD34+ selection systems or CAMPATH-1.
Dreger P; Viehmann K; Steinmann J; Eckstein V; Müller-Ruchholtz W; Löffler H; Schmitz N
Exp Hematol; 1995 Feb; 23(2):147-54. PubMed ID: 7530212
[TBL] [Abstract][Full Text] [Related]
12. Comparison of efficiency of complements from various species for T-cell depletion from Cercopithecus aethiops bone marrow with Campath-1 MoAb in vitro.
Phan DT; Gidáli J; Fehér I; Harsányi V; Petrányi GG; Hollán SR
Haematologia (Budap); 1987; 20(4):203-13. PubMed ID: 3501389
[TBL] [Abstract][Full Text] [Related]
13. Use of limiting dilution analysis to assess residual T cell content in human marrow after treatment with monoclonal anti-T cell antibody and complement.
Cooley MA; Thornton M; Wong KL; Atkinson K; Biggs J
Transplant Proc; 1986 Apr; 18(2):337-9. PubMed ID: 3485845
[No Abstract] [Full Text] [Related]
14. Monoclonal rat anti-human lymphocyte antibody Campath-1 binds to T and B lymphocytes but effectively lyses only T cells.
Gazitt Y; Or R; Mumcuoglu M; Slavin S
Bone Marrow Transplant; 1987 Dec; 2(4):427-33. PubMed ID: 3332190
[TBL] [Abstract][Full Text] [Related]
15. Suppression of natural killer cell differentiation by activated T lymphocytes in long-term cultures of mouse bone marrow.
Delfino DV; Lepri E; Ayroldi E; Migliorati G; Boggs SS; Riccardi C
Exp Hematol; 1998 Jan; 26(1):2-9. PubMed ID: 9430508
[TBL] [Abstract][Full Text] [Related]
16. Effect of bone marrow T lymphocytes treated with CAMPATH 1G on megakaryocyte colony formation.
Deutsch VR; Nagler A; Slavin S; Condiotti R; Levine RF; Eldor A
Exp Hematol; 1993 Oct; 21(11):1427-35. PubMed ID: 8405223
[TBL] [Abstract][Full Text] [Related]
17. T cell depletion of bone marrow for clinical marrow allografting: optimalization of conditions for depletion by anti-CD2 and anti-CD8 monoclonal antibodies with rabbit complement, and for detection of residual T cell content.
Cooley MA; Farrelly H; O'Flaherty E; Biggs JC; Atkinson K
Pathology; 1987 Apr; 19(2):131-6. PubMed ID: 2899866
[TBL] [Abstract][Full Text] [Related]
18. The effect of in vitro T lymphocyte depletion on generation of IL2-activated cytotoxic cells.
Morecki S; Nabet C; Ackerstein A; Schlesinger M; Slavin S
Bone Marrow Transplant; 1991 Apr; 7(4):269-73. PubMed ID: 2070132
[TBL] [Abstract][Full Text] [Related]
19. The use of VEP13 monoclonal antibody for definition of natural killer cells: spontaneous killer cells directed against fresh human leukaemia cells carry the VEP13 antigen.
Ziegler-Heitbrock HW; Fütterer A; Rumpold H; Kraft D; Munker R; Riethmüller G
Clin Exp Immunol; 1984 Nov; 58(2):470-7. PubMed ID: 6333947
[TBL] [Abstract][Full Text] [Related]
20. Depletion of human T cells from bone marrow by monoclonal antibodies and complement.
Lieu CW; Wang SY; Ho CK; Chen PM; Chien KY
Zhonghua Yi Xue Za Zhi (Taipei); 1987 Oct; 40(4):349-56. PubMed ID: 3332232
[No Abstract] [Full Text] [Related]
[Next] [New Search]
